• Corpus ID: 40448967

The influence of a single dose of vasopressin analogs on human renal potassium excretion.

  title={The influence of a single dose of vasopressin analogs on human renal potassium excretion.},
  author={H. N{\'a}dvorn{\'i}kov{\'a} and Otto Sch{\"u}ck},
  journal={International journal of clinical pharmacology, therapy, and toxicology},
  volume={20 4},
  • H. Nádvorníková, O. Schück
  • Published 1 April 1982
  • Medicine, Biology
  • International journal of clinical pharmacology, therapy, and toxicology
The effect of intranasal administration of 10 micrograms of 1-deamino-8-d-arginine vasopressin (DDAVP) and intravenous administration of 200 micrograms of N-glycyl-glycyl-glycyl-lysin-vasopressin (TGLVP) on urinary concentration (UK) and fractional excretion (FEK) of potassium was investigated in healthy subjects. For comparison the same parameters were followed under conditions of 36-h water-intake restriction. Once the maximally concentrated urine had been reached, the average value of UK… 
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
The mechanisms by which arginine vasopressin (AVP) exerts its antidiuretic and pressor effects, via activation of V2 and V1a receptors, respectively, are relatively well understood, but the possible
Terlipressin causing a hyponatraemic seizure
The patient the authors report here is unique, with the rapid onset of hyponatraemia and associated seizure due to Terlipressin, and the case demonstrates the need for frequent electrolyte monitoring whilst administering the drug.
Safety of Terlipressin for Hepatorenal Syndrome
Terlipressin is contraindicated or should be used with extreme caution in patients with severe atherosclerotic cardiovascular disease and prevention and handling of side effects include careful selection of patients, close surveillance, daily consideration of dose and duration of therapy.
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
Treatment with terlipressin and albumin is considered the most efficient therapy and should therefore be recommended for the treatment of type 1 HRS-1.
Rein, vasopressine et pression artérielle : importance de la concentration de l'urine et du rythme nycthéméral d'excrétion d'eau et de sodium
La vasopressine (AVP), ou hormone antidiuretique, a deux effets majeurs : 1°) des effets sur la permeabilite a l'eau du canal collecteur renal, medies par les recepteurs V2, qui permettent la
Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding
The presence of HBV, DM, the baseline serum sodium, shock on admission, and especially baseline creatinine may be predictive of the development of hyponatremia after terlipressin treatment.
The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
The study supports earlier findings and suggests a dose level of TGLVP for the use in excision of burns, which is less sensitive for detecting effects of T GLVP than laser Doppler flowmetry.